Acrivon Therapeutics, Inc. Common Stock (ACRV) has a market capitalization of $51.75M and trades at $1.64. The 52-week range is 1.05-3.56.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.8, Earnings Per Share (EPS) of $-2.02.
The stock has a beta of 1.74, operates in the Healthcare sector.
